Your browser doesn't support javascript.
loading
Safety and Efficacy of Denosumab for Fibrous Dysplasia of Bone.
de Castro, Luis F; Michel, Zachary; Pan, Kristen; Taylor, Jocelyn; Szymczuk, Vivian; Paravastu, Sriram; Saboury, Babak; Papadakis, Georgios Z; Li, Xiaobai; Milligan, Kelly; Boyce, Brendan; Paul, Scott M; Collins, Michael T; Boyce, Alison M.
Affiliation
  • de Castro LF; National Institutes of Health, Bethesda, MD.
  • Michel Z; National Institutes of Health, Bethesda, MD.
  • Pan K; National Institutes of Health, Bethesda, MD.
  • Taylor J; National Institutes of Health, Bethesda, MD.
  • Szymczuk V; National Institutes of Health, Bethesda, MD.
  • Paravastu S; National Institutes of Health, Bethesda, MD.
  • Saboury B; National Institutes of Health, Bethesda, MD.
  • Papadakis GZ; Foundation for Research and Technology, Heraklion, Greece.
  • Li X; National Institutes of Health, Bethesda, MD.
  • Milligan K; National Institutes of Health, Bethesda, MD.
  • Boyce B; University of Rochester Medical Center, Rochester, NY.
  • Paul SM; National Institutes of Health, Bethesda, MD alison.boyce@nih.gov.
  • Collins MT; National Institutes of Health, Bethesda, MD alison.boyce@nih.gov.
  • Boyce AM; National Institutes of Health, Bethesda, MD alison.boyce@nih.gov.
N Engl J Med ; 388(8): 766-768, 2023 02 23.
Article in En | MEDLINE | ID: mdl-36812441

Full text: 1 Database: MEDLINE Main subject: Bone Density Conservation Agents / Fibrous Dysplasia of Bone / Denosumab Limits: Humans Language: En Journal: N Engl J Med Year: 2023 Type: Article Affiliation country: Moldova

Full text: 1 Database: MEDLINE Main subject: Bone Density Conservation Agents / Fibrous Dysplasia of Bone / Denosumab Limits: Humans Language: En Journal: N Engl J Med Year: 2023 Type: Article Affiliation country: Moldova